Lymphangioleiomyomatosis (LAM) is a multisystem disorder characterized by cystic lung disease and abdominal tumors (lymphangiomyomas and angiomyolipomas). The disease, which presents almost exclusively in women of childbearing age, is characterized by the proliferation of abnormal smooth muscle containing premelanosomal structures similar to those found in melanoma cells. A clinical protocol has enabled the Branch to assemble a large cohort of patients with LAM and to document the natural history of the disease, the histopathological findings, the radiographic abnormalities, and characteristic pulmonary function abnormalities. It has enabled us to obtain tissue to examine gene expression and cell regulatory pathways. We have been able to grow LAM cells from lungs of patients with LAM, obtained at transplant or autopsy. Cells from angiomyolipoma, obtained immediately following surgical removal are also growing in culture. Several clinical observations have changed clinical care for patients with LAM. First, patients were found to have an increased frequency of bone loss, with about 80% of patients exhibiting either osteopenia or osteoporosis. Second, patients with LAM have been known to develop pleural and pericardial effusions. Closer analysis of patients with pericardial effusions revealed that they may develop constrictive pericarditis. Third, patients with LAM are known to have abdominal tumors termed lymphangiomyomas. The tumors are benign. However, we have observed that their enlargement may result in neurological compromise in the lower extremities, abdominal bloating, peripheral edema, and lymphedema. Fourth, we have observed that a high percentage of patients with LAM have airway hyperresponsiveness. - lymphangioleiomyomatosis, cystic lung disease, osteoporosis,asthma - Human Subjects
| Aldrich, Capt Shelley L; Hong, Chien-Hui; Groves, Leslie et al. (2010) Acral lesions in tuberous sclerosis complex: insights into pathogenesis. J Am Acad Dermatol 63:244-51 |
| Taveira-DaSilva, Angelo M; Burstein, Dara; Hathaway, Olanda M et al. (2009) Pneumothorax after air travel in lymphangioleiomyomatosis, idiopathic pulmonary fibrosis, and sarcoidosis. Chest 136:665-70 |
| Glasgow, Connie G; Avila, Nilo A; Lin, Jing-Ping et al. (2009) Serum vascular endothelial growth factor-D levels in patients with lymphangioleiomyomatosis reflect lymphatic involvement. Chest 135:1293-300 |
| Taveira-Dasilva, Angelo M; Steagall, Wendy K; Rabel, Antoinette et al. (2009) Reversible Airflow Obstruction in Lymphangioleiomyomatosis. Chest : |
| El-Chemaly, Souheil; Malide, Daniela; Zudaire, Enrique et al. (2009) Abnormal lymphangiogenesis in idiopathic pulmonary fibrosis with insights into cellular and molecular mechanisms. Proc Natl Acad Sci U S A 106:3958-63 |
| El-Chemaly, Souheil; Levine, Stewart J; Moss, Joel (2008) Lymphatics in lung disease. Ann N Y Acad Sci 1131:195-202 |
| Harari, Sergio; Cassandro, Roberto; Chiodini, Iacopo et al. (2008) Effect of a gonadotrophin-releasing hormone analogue on lung function in lymphangioleiomyomatosis. Chest 133:448-54 |
| Glasgow, Connie G; Taveira-Dasilva, Angelo M; Darling, Thomas N et al. (2008) Lymphatic involvement in lymphangioleiomyomatosis. Ann N Y Acad Sci 1131:206-14 |
| Li, Shaowei; Takeuchi, Fumiko; Wang, Ji-An et al. (2008) Mesenchymal-epithelial interactions involving epiregulin in tuberous sclerosis complex hamartomas. Proc Natl Acad Sci U S A 105:3539-44 |
| Taveira-DaSilva, Angelo M; Hathaway, Olanda M; Sachdev, Vandana et al. (2007) Pulmonary artery pressure in lymphangioleiomyomatosis: an echocardiographic study. Chest 132:1573-8 |
Showing the most recent 10 out of 46 publications
